Expand RADX Menu
RADX MENU

RADX Latest Press Releases

-- May 14, 2026 --

A Cancer Antigen Long Thought Untouchable Is Suddenly the Hottest Target in Oncology Globe Newswire 9:15 AM

-- April 29, 2026 --

Deutsche Bank ADR Virtual Investor Conference: Presentations Now Available for Online Viewing Globe Newswire 8:44 AM

-- April 23, 2026 --

International companies to host live webcasts at Deutsche Bank's Depositary Receipts Virtual Investor Conference on April 28, 2026 Globe Newswire 8:35 AM
Radiopharm Theranostics Reports Business Update Globe Newswire 7:00 AM

-- April 20, 2026 --

Radiopharm Theranostics Presents Initial Findings from Phase 1 First-in-Human HEAT Clinical Trial for 177Lu-RAD202 in HER2+ Solid Tumors at American Association for Cancer Research 2026 Globe Newswire 7:00 AM

-- April 16, 2026 --

Radiopharm Theranostics Completes Enrollment in U.S. Phase 2b Imaging Trial of RAD 101 for Diagnosis of Brain Metastases Globe Newswire 7:00 AM

-- April 8, 2026 --

Radiopharm Theranostics Advances to Cohort 3 in 177Lu-RAD202 Phase 1 Dose Escalating Clinical Trial Globe Newswire 7:00 AM

-- April 7, 2026 --

Radiopharm Theranostics and Siemens Healthineers Sign Clinical Supply Agreement for RAD101 in the U.S. Globe Newswire 7:00 AM

-- March 27, 2026 --

Radiopharm Theranostics Doses First Patient in Phase 1 Clinical Study of RAD 402 in Advanced Prostate Cancer Globe Newswire 7:00 AM

-- March 24, 2026 --

Radiopharm Theranostics Achieves Primary Endpoint In 90% of Patients At Second Interim Analysis of RAD 101 Phase 2b Imaging Trial in Brain Metastases Globe Newswire 7:00 AM

-- February 24, 2026 --

Radiopharm Theranostics Doses First Patient in Phase 1/2a Clinical Study of BetaBart (RV-01) Globe Newswire 7:30 AM
Market Data Delayed 15 Minutes